NCT04133116View on ClinicalTrials.gov

A Study of LY3471851 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 29, 2019

Primary Completion Date

March 6, 2020

Study Completion Date

March 6, 2020

Conditions
Healthy
Interventions
DRUG

LY3471851

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (1)

90630

WCCT Global, Cypress

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Nektar Therapeutics

INDUSTRY